Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Natco Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Panacea Biotec Enters into Agreement with Natco Pharma and Breckenridge Pharma 12
Licensing Agreements 13
Natco Pharma Enters into Licensing Agreement with Gilead Sciences 13
Cipla, Emcure Pharma, Hetero Drugs, Natco Pharma and Aurobindo Pharma Enter into Licensing Agreement with Medicines Patent Pool and Bristol-Myers Squibb 14
Equity Offering 15
Natco Pharma Plans to Raise up to USD232 Million in Public Offering of Shares 15
Natco Pharma Raises USD54.5 Million in Private Placement of Shares 16
Natco Pharma Completes Private Placement Of Shares For US$18 Million 17
Debt Offering 18
Natco Pharma Plans Private Placement Of Debentures For US$24.3 Million 18
Acquisition 19
Kotak Private Equity Sells 1.18% Stake In Natco Pharma 19
Natco Pharma Acquires 51% Stake In Natco Organics From Tamilnadu Industrial Development 20
Natco Pharma Ltd – Key Competitors 21
Natco Pharma Ltd – Key Employees 22
Natco Pharma Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 24
Recent Developments 25
Financial Announcements 25
Nov 05, 2018: NATCO records INR 583.40 Crores consolidated revenue and INR 181.50 crore of profit, after tax, for the second quarter, FY 2018-19 25
Aug 08, 2018: NATCO records INR 574.5 Crores consolidated revenue and INR 181.1 Crore of profit, after tax, for the First Quarter, FY2018-19 26
May 23, 2018: NATCO records INR 2,242 Crore consolidated revenue and INR 695 Crore of profit, after tax, for the full year ended March 2018 27
Feb 06, 2018: NATCO records INR 573.6 Crore revenue and INR 217.4 Crore of Profit, after tax, for the Third Quarter, FY 2017-18 28
Aug 07, 2017: NATCO Pharma Reports Financial Results For The Quarter Ended 30 June 2017 29
May 30, 2017: NATCO records INR 2078.9 Crore total consolidated revenue and INR 486.0 Crore of profit, after tax, for the full year ended March 2017 30
Feb 14, 2017: NATCO records INR 685.13 Crore total consolidated revenue and INR 194.76 Crore of profit, after tax, for the Third Quarter, FY 2017 14 February 2017 31
Corporate Communications 32
Aug 07, 2017: Natco Pharma Announces Resignation of Directors 32
Legal and Regulatory 33
Feb 17, 2018: USFDA completes inspection of Natco’s Mekaguda API facility with zero observations 33
Jul 20, 2017: NATCO receives establishment inspection report (EIR) from U.S. food and drug administration (FDA) 34
Jan 25, 2017: NATCO updates on USFDA inspection at its Kothur Formulation Facility 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Natco Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Natco Pharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Panacea Biotec Enters into Agreement with Natco Pharma and Breckenridge Pharma 12
Natco Pharma Enters into Licensing Agreement with Gilead Sciences 13
Cipla, Emcure Pharma, Hetero Drugs, Natco Pharma and Aurobindo Pharma Enter into Licensing Agreement with Medicines Patent Pool and Bristol-Myers Squibb 14
Natco Pharma Plans to Raise up to USD232 Million in Public Offering of Shares 15
Natco Pharma Raises USD54.5 Million in Private Placement of Shares 16
Natco Pharma Completes Private Placement Of Shares For US$18 Million 17
Natco Pharma Plans Private Placement Of Debentures For US$24.3 Million 18
Kotak Private Equity Sells 1.18% Stake In Natco Pharma 19
Natco Pharma Acquires 51% Stake In Natco Organics From Tamilnadu Industrial Development 20
Natco Pharma Ltd, Key Competitors 21
Natco Pharma Ltd, Key Employees 22
Natco Pharma Ltd, Other Locations 23
Natco Pharma Ltd, Subsidiaries 23
Natco Pharma Ltd, Joint Venture 24
List of Figures
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9